Fig. 8From: Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cellsGraphical abstract showing the anti-neuroinflammatory effects of the KIT 17 in LPS-activated microglia. The anti-inflammatory effects of KIT 17 included the reduction of COX-2/mGES-1 levels as well as potent inhibition of PGE2 productionBack to article page